Skip to main content

Nasdaq Earnings

2 REITS Likely to Turn Out Winners This Earnings Season

3 years 4 months ago
The first-quarter reporting cycle is underway, and investors can be lured by the profits of companies that have already released their quarterly figures. However, rather than adding the stock later to your portfolio, accumulating the ones poised to beat estimates can gene
Zacks

Hershey Hits the Sweet Spot with Sales, Earnings Growth

3 years 4 months ago
In turbulent and uncertain markets, investors turn to reliable dividend payers and well-known names. Consumer spending on snacks and sweets haven't sacrificed due to recession fears, including in strong recent price gains in stocks like PepsiCo Inc. (NYSE: PEP), Mondelez Intern
MarketBeat

Analyzing the Q1 Earnings Landscape

3 years 4 months ago
Note: The following is an excerpt from this week’s Earnings Trends report. You can access the full report that contains detailed historical actual and estimates for the current and following periods, please click here>>>
Zacks

Analyzing the Q1 Earnings Landscape

3 years 4 months ago
Note: The following is an excerpt from this week’s Earnings Trends report. You can access the full report that contains detailed historical actual and estimates for the current and following periods, please click here>>>
Zacks

Starbucks Stock Becomes a Value Play

3 years 4 months ago
Valuing a business need not be so focused on theoretical methods and mathematical calculations; while they can be - and oftentimes are - the foundation to beginning to understand the intrinsic value, there are other qualitative factors. For example, Apple (NASDAQ: AAPL) is a gre
MarketBeat

3 Insurers Poised to Beat Estimates This Earnings Season

3 years 4 months ago
Per the latest Earnings Preview, the Finance sector’s first-quarter 2023 earnings are expected to increase 7.5%. Revenues are estimated to rise 13.1%. Results of Insurance, one of the Finance sector industries, are likely to reflect better pricing and exposure growth, acc
Zacks

Will Forced Divesture Of Grail Boost Illumina Shareholder Value?

3 years 4 months ago
The phrase, “I’m from the government and I’m here to help” has a well-deserved reputation as a terrifying phrase, but for medical researcher Illumina Inc. (NASDAQ: ILMN), which specializes in DNA sequencing, government meddling could actually end up helping shareholders.  That “
MarketBeat
Checked
28 minutes 37 seconds ago
This feed is responsible for generating the rss feed related to the topic Earnings
Subscribe to Nasdaq Earnings feed